AGITG Outstanding Site Awards

Sites participating in clinical trials play a crucial role in their conduct and delivery. We rely on the expertise, patient engagement and commitment of the site staff to promote our research and recruit effectively, so that we improve outcomes for patients with GI cancer.

The Outstanding Site Awards recognise clinical trial sites that have shown exceptional enthusiasm, performance and dedication to conducting AGITG trials.

There are two categories for the Outstanding Site Award:

  • Metropolitan
  • Regional, Rural and Remote

All clinical trial sites actively involved in AGITG Studies are encouraged to apply. Please complete the web form to request an application form.

Award recipients will receive a trophy, two complimentary registrations to the 2024 AGITG Annual Scientific Meeting, recognition of achievement on the AGITG website and member newsletter, and kudos from within the AGITG Network.


2023 Metropolitan Recipient: St John of God Hospital Subiaco

The 2023 Outstanding Metropolitan Site Award was presented to St John of God Hospital Subiaco on Wednesday 15 November 2023, during the AGITG ASM. Tara McSweeney accepted the award on behalf of the team. Read more about their award

2023 Regional, Rural and Remote Recipient: Illawarra Shoalhaven Local Health District

The 2023 Outstanding RRR Site Award was presented to Illawarra Shoalhaven Local Health District on Wednesday 15 November 2023, during the AGITG ASM. Kyrie Rodgers accepted the award on behalf of the team. Read more about their award

2022 Metropolitan Recipient: Royal Brisbane and Women’s Hospital

The 2022 Outstanding Metropolitan Site Award was presented to Royal Brisbane and Women’s Hospital on Wednesday 16 November 2022, during the AGITG ASM. Deputy Director of Medical Oncology A/Prof Melissa Eastgate accepted the award on behalf of the team.

2022 Regional, Rural and Remote Recipient: Bendigo Health

The 2022 Outstanding Regional, Rural and Remote Site Award was presented to Bendigo Health on Wednesday 16 November 2022, during the AGITG ASM. Cancer Research Manager Narelle McPhee and Clinical Trials Fellow Dr Chloe Georgiou accepted the award on behalf of the team.

2021 Recipient: Western Health

The 2021 Outstanding Site Award was presented to Western Health on Friday 15 October 2021, during the AGITG ASM. Cancer Research Manager at Western Health, Heike Raunow accepted the award on behalf of the team.

Western Health receives the award for their dedication to AGITG trials as the highest recruiting site for the DYNAMIC-III colon cancer trial and second highest recruiting site for the DYNAMIC-Rectal study. They currently have more than 121 participants in AGITG studies.

2020 Recipient: Monash Medical Centre

At the 2020 AGITG Annual Scientific Meeting held virtually on 28 August, Dr Lorraine Chantrill awarded the Outstanding Site Award to Monash Medical Centre. Karen Gillett, Unit Manager at Monash Medical Centre, accepted the Award on behalf of the team. 

Dr Lorraine Chantrill, Chair of the AGITG, says, “The dedication of the staff at Monash Health to giving GI cancer patients the option of a clinical trial means that their patients have the opportunity to directly participate in GI cancer research.”

2019 Recipient: Calvary Mater Newcastle

Naomi Knoblauch received the AGITG Outstanding Site Award on behalf of Calvary Mater Newcastle Hospital.